SBRI19015U Clinical Translational Medicine

Volume 2025/2026
Education

BRIDGE – Translational Excellence Programme

Content

Understanding the mechanisms behind major health disorders – such as infectious diseases, heart, liver, and lung conditions, diabetes, rheumatoid arthritis, and cancer – is crucial for developing new treatments. This process often involves translating research from the laboratory to the clinic and vice versa. However, bridging this gap can be challenging. The BRIDGE Clinical Translational Medicine course addresses these challenges by introducing key concepts and issues in clinical translational research, supported by real-world examples that illustrate how basic and clinical research can inform one another.

Learning Outcome

Upon completing the course, participants should be able to:

 

Knowledge

  • Understand how comprehensive characterisation of individual patients or their samples –using molecular, immunological, genetic, and proteomic analyses – can guide personalised treatment strategies.
  • Explain how findings from biological experiments (e.g., in vitro studies and animal models) can inform the design of clinical investigations.
  • Discuss how biological research contributes to the drug development process.
  • Understand the process of advancing a preclinical drug candidate to a Phase 1 clinical trial.

 

Skills

  • Integrate knowledge obtained from other courses into translational clinical research.
  • Critically evaluate preclinical data – from a clinical point of view.
  • Generate novel ideas for clinical trials from preclinical observations.
  • Implement research results in clinical practice.
  • Solve unmet clinical needs/questions by designing the clinically relevant preclinical/ biological experiments.
  • Practice how to be a moderator of a scientific discussion.
     

Competences

  • Integrate basic biology into clinical knowledge.
  • Assess ethical considerations of how to implement new molecular tools and conduct studies with patients.
  • Understand the central aspects of clinical translational medicine and be able to discuss and communicate these to other scientists, clinicians, and the public.

The course literature will be listed on Absalon.

Participants must meet the admission criteria of the BRIDGE – Translational Excellence Programme.
Cathedral lectures and discussion sessions.

The course will end with an evaluation, where participants must reflect on the course learning outcomes and provide feedback for course development.
  • Category
  • Hours
  • Lectures
  • 24
  • Class Instruction
  • 1
  • Preparation
  • 4
  • Exercises
  • 1
  • Total
  • 30
Oral
Continuous feedback during the course of the semester
Credit
0 ECTS
Type of assessment
Continuous assessment
Requirement to attend classes
Type of assessment details
Attendance and active participation are required, including moderating two lectures.
Examination prerequisites

Participants are automatically registered for the examination upon admission to the BRIDGE – Translational Excellence Programme.

Aid
All aids allowed
Marking scale
passed/not passed
Censorship form
No external censorship
Criteria for exam assesment

Active contribution and course participation according to the BRIDGE Guidelines and Practicalities.